(Q46823376)

English

Dual blockade of the rennin-angiotensin system versus maximal recommended dose of angiotensin II receptor blockade in chronic glomerulonephritis

scientific article published on 5 January 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18175062

Dual blockade of the rennin-angiotensin system versus maximal recommended dose of angiotensin II receptor blockade in chronic glomerulonephritis (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18175062

glomerulonephritis

1 reference

based on heuristic

inferred from title

author name string

Urara Mori-Takeyama

1

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18175062

Shinya Minatoguchi

2

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18175062

Ichijirou Murata

3

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18175062

Hisayoshi Fujiwara

4

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18175062

Yoko Ozaki

5

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18175062

Michiya Ohno

6

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18175062

Hiroshi Oda

7

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18175062

Hiroshige Ohashi

8

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18175062

publication date

5 January 2008

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18175062

Clinical and experimental nephrology

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18175062

12

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18175062

1

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18175062

33-40

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18175062

https://scigraph.springernature.com/pub.10.1007/s10157-007-0013-6

0 references

Cough and angioneurotic edema associated with angiotensin-converting enzyme inhibitor therapy. A review of the literature and pathophysiology

1 reference

https://api.crossref.org/works/10.1007%2FS10157-007-0013-6

21 January 2018

Chronic renal diseases: renoprotective benefits of renin-angiotensin system inhibition

1 reference

https://api.crossref.org/works/10.1007%2FS10157-007-0013-6

21 January 2018

Tubulointerstitial changes as a major determinant in the progression of renal damage

1 reference

https://api.crossref.org/works/10.1007%2FS10157-007-0013-6

21 January 2018

Will angiotensin II receptor antagonists be renoprotective in humans?

1 reference

https://pubmed.ncbi.nlm.nih.gov/18175062

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Blood pressure-independent effect of angiotensin inhibition on vascular lesions of chronic renal failure

1 reference

https://pubmed.ncbi.nlm.nih.gov/18175062

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antiproteinuric effect of blood-pressure-lowering agents: a meta-analysis of comparative trials.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18175062

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The antiproteinuric action of angiotensin-converting enzyme is dependent on kinin

1 reference

https://pubmed.ncbi.nlm.nih.gov/18175062

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE): a randomised controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/18175062

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of combined ACE inhibitor and angiotensin II antagonist treatment in human chronic nephropathies

1 reference

https://pubmed.ncbi.nlm.nih.gov/18175062

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Progressive renal and cardiovascular disease: Optimal treatment strategies

1 reference

https://pubmed.ncbi.nlm.nih.gov/18175062

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Angiotensin II receptor blockade limits glomerular injury in rats with reduced renal mass

1 reference

https://pubmed.ncbi.nlm.nih.gov/18175062

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The renoprotective properties of angiotensin-converting enzyme inhibitors in a chronic model of membranous nephropathy are solely due to the inhibition of angiotensin II: evidence based on comparative studies with a receptor antagonist

1 reference

https://pubmed.ncbi.nlm.nih.gov/18175062

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/18175062

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dual renin-angiotensin system blockade at optimal doses for proteinuria

1 reference

https://pubmed.ncbi.nlm.nih.gov/18175062

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of combination therapy with enalapril and losartan on the rate of progression of renal injury in rats with 5/6 renal mass ablation

1 reference

https://pubmed.ncbi.nlm.nih.gov/18175062

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A subdepressor low dose of ramipril lowers urinary protein excretion without increasing plasma potassium

1 reference

https://pubmed.ncbi.nlm.nih.gov/18175062

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bradykinin decreases plasminogen activator inhibitor-1 expression and facilitates matrix degradation in the renal tubulointerstitium under angiotensin-converting enzyme blockade

1 reference

https://pubmed.ncbi.nlm.nih.gov/18175062

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The June 2003 Barry M. Brenner Comgan lecture. The future of renoprotection: frustration and promises.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18175062

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Coadministration of losartan and enalapril exerts additive antiproteinuric effect in IgA nephropathy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18175062

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on blood pressure and the kidney

1 reference

https://pubmed.ncbi.nlm.nih.gov/18175062

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bradykinin and renal fibrosis: have we ACE'd it?

1 reference

https://pubmed.ncbi.nlm.nih.gov/18175062

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/18175062

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Progression of chronic renal failure

1 reference

https://pubmed.ncbi.nlm.nih.gov/18175062

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Differential effects of calcium antagonist subclasses on markers of nephropathy progression

1 reference

https://pubmed.ncbi.nlm.nih.gov/18175062

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Maximal suppression of renin-angiotensin system in nonproliferative glomerulonephritis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18175062

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High prevalence of persistent cough with angiotensin converting enzyme inhibitors in Chinese

1 reference

https://pubmed.ncbi.nlm.nih.gov/18175062

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combination ACEI and ARB therapy: additional benefit in renoprotection?

1 reference

https://pubmed.ncbi.nlm.nih.gov/18175062

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Safety of the combination of valsartan and benazepril in patients with chronic renal disease. European Group for the Investigation of Valsartan in Chronic Renal Disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/18175062

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>

1 reference

https://pubmed.ncbi.nlm.nih.gov/18175062

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Additive antiproteinuric effect of converting enzyme inhibitor and losartan in normotensive patients with IgA nephropathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/18175062

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

ACE inhibitors versus AT(1) receptor antagonists in patients with chronic renal disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/18175062

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dual blockade of the renin-angiotensin system compared with a 50% increase in the dose of angiotensin-converting enzyme inhibitor: effects on proteinuria and blood pressure

1 reference

https://pubmed.ncbi.nlm.nih.gov/18175062

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S10157-007-0013-6

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18175062

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18175062

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46823376&oldid=2133718280"